Business
MEDI: Record revenue and stable profit in 2024, with strong AMERICAS growth and higher dividend
MEDI: Record revenue and stable profit in 2024, with strong AMERICAS growth and higher dividend
About this update from Medistim Asa
Record sales and stable profitability in 2024, with strong growth in AMERICAS and EMEA offsetting APAC weakness. Investments in innovation and commercial operations continue, supporting future growth ambitions and a proposed dividend increase to NOK 6.00 per share.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.